BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19860646)

  • 1. Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options.
    Maltezou HC; Tsiodras S
    Curr Drug Targets; 2009 Oct; 10(10):1041-8. PubMed ID: 19860646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stockpiling antiviral drugs for the next influenza pandemic.
    Patel A; Gorman SE
    Clin Pharmacol Ther; 2009 Sep; 86(3):241-3. PubMed ID: 19707215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.
    Wong JP; Christopher ME; Viswanathan S; Dai X; Salazar AM; Sun LQ; Wang M
    Curr Pharm Des; 2009; 15(11):1269-74. PubMed ID: 19355966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic influenza: is an antiviral response realistic?
    Hayden FG
    Pediatr Infect Dis J; 2004 Nov; 23(11 Suppl):S262-9. PubMed ID: 15577582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in and shortcomings of drug stockpiling, vaccine development and related policies during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.
    Mei L; Tang Q; Cui YM; Tobe RG; Selotlegeng L; Ali AH; Xu LZ
    Drug Discov Ther; 2013 Jun; 7(3):95-100. PubMed ID: 23917856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparing for the next influenza pandemic.
    McCullers JA
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S57-9. PubMed ID: 18820579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. John F. Enders lecture 2006: antivirals for influenza.
    Ong AK; Hayden FG
    J Infect Dis; 2007 Jul; 196(2):181-90. PubMed ID: 17570104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines and antiviral drugs in pandemic preparedness.
    Monto AS
    Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy.
    Pizzorno A; Padey B; Terrier O; Rosa-Calatrava M
    Front Immunol; 2019; 10():531. PubMed ID: 30941148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic influenza: overview of vaccines and antiviral drugs.
    Cox MM
    Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of neuraminidase inhibitors to combat pandemic influenza.
    Democratis J; Pareek M; Stephenson I
    J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal and pandemic influenza preparedness: science and countermeasures.
    Fauci AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S73-6. PubMed ID: 17163392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.